SillaJen Employee Directory

Biotechnology ResearchCalifornia, United States51-200 Employees

SillaJen Biotherapeutics, Inc. is located in San Francisco, one of the largest and most innovative biotech clusters in the world. Sillajen Biotherapeutics focuses on the research, development and manufacturing of oncolytic viruses to treat cancer; we are responsible for Clinical Operations, Regulatory Affairs, Research and Development, Manufacturing, Alliance Management and Accounting for clinical trials.

SillaJen, Inc. is a South Korean based biotechnology company headquartered in Busan South Korea, with satellite offices in Seoul, South Korea and San Francisco, CA.  The company is focused on the development and commercialization of oncolytic immunotherapy products using the SOLVETM platform, including its lead product Pexa-Vec, which is currently in Phase 3 trials for the treatment of advanced primary liver cancer. Additional information about SillaJen is available at www.sillajen.com.

Find SillaJen employees' phone numbers or email addresses

SillaJen Global Highlights

Location
Employees

North America
20

Minus sign iconPlus sign icon
  • United States Of America
    19
  • Canada
    1

Oceania
2

Minus sign iconPlus sign icon
  • New Zealand
    1
  • Australia
    1

SillaJen's Leadership

  • Stylized image of a person
    M. L.
    Chief Operations Officer, Head Of Cmc
    Phone icon
  • Stylized image of a person
    M. S.
    Chief Financial Officer
    Phone icon
  • Stylized image of a person
    최. K. C.
    Vice President Of Commerce
    Phone icon
  • Stylized image of a person
    S. P.
    Head Of Research And Development, Ceo Of Sillajen Us
    Phone icon
  • Stylized image of a person
    J. S. C.
    Director
    Phone icon
  • Stylized image of a person
    D. C.
    Director New Drug Development
    Phone icon
  • Stylized image of a person
    L. J. G.
    Director
    Phone icon
  • Stylized image of a person
    N. D. S.
    Associate Director, Preclinical And Translational Science
    Phone icon

Contact profiles from SillaJen

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    Z. A.
    Senior Manager, Corporate Accounting & Finance
    Phone icon
    Bay
    Nov 17, 2025
  • Stylized image of a person
    J. M.
    Clinical Research Associate
    Phone icon
    United StatesNew York
    Jul 19, 2023
  • Stylized image of a person
    M. S.
    In House Counsel
    Phone icon
    AustraliaAct
    Feb 22, 2024
  • Stylized image of a person
    S. 보.
    Advisor
    Phone icon
    South Korea
    Mar 05, 2024
  • Stylized image of a person
    M. S.
    Phone icon
    UNITED STATES
    Mar 07, 2023

Frequently Asked Questions

What is SillaJen known for?

Minus sign iconPlus sign icon
SillaJen was founded in 2003 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore SillaJen's company overview page for more information.

What is SillaJen's most common email format?

Minus sign iconPlus sign icon
SillaJen employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more SillaJen email formats with LeadIQ.

How many employees does SillaJen have currently?

Minus sign iconPlus sign icon
SillaJen has approximately 51 employees as of December 2025. These team members are located across 2 continents, including North AmericaOceania.

Who are SillaJen's key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, SillaJen's key employees include:

  • Chief Operations Officer, Head Of Cmc: M. L.
  • Chief Financial Officer: M. S.
  • Vice President Of Commerce: 최. K. C.
  • Head Of Research And Development, Ceo Of Sillajen Us: S. P.
  • Director: J. S. C.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.